10th Annual Parkinsons Golf Classic
June 8, 2009
Philmont Country Club
Huntintgton Valley, PA
The Council’s annual golf tournament is our major fundraiser. Here’s your chance to show your support and enjoy yourself at the same time!
Yoga for Parkinson’s
The Council runs a number of different yoga classes. Find the right one for you. Check here for details.
Research Volunteers Needed
Keep on top of the latest news around Parkinson Disease. Sign up now.
Make a Donation
The Council relies on the generosity of others. Please give today.
NET-PD Creatine Study-NIH Exploratory Trials in Parkinson Disease
General Information
The NET-PD clinical trails group will test creatine, a nutritional supplement to determine if it slow clinical decline in patients with PD.
In this study, 172 men and women were early, treated PD will receive the investigational drug creation or a matching placebo (an inactive substance). Each participant will have a 50% chance of receiving the creatine.
The Drug
Creatine is widely used dietary supplement thoguyt to improve exercise performance. Creatine has not been approved to treat PD. In animal models and human studies, creatine has been shown to be well tolerated and may have some ability to protect brain cells.
Some of the known side effects of creatine are weight gain, swelling in the arms or legs, nausea, vomiting and diarrhea. Side effects that are rare include muscle cramps and liver or kidney problems.
Eligibility Criteria
You may be eligible to participate in their study if:
- You are willing and able to give informed consent and comply with study requirements
- You have been diagnosed with PD within the last 5 years
- You are receiving medications to treat your PD ( the study staff will review your medications to determine if you are eligible)
You may not be eligible to participate if:
- You have used creatine within the 2 weeks before entering the study.
- You have participated in another drug trial within the month before the start date of the NET-PD study.
- You have a know sensitivity to creatine
- The study team does not feel you overall medical condition is such that it would be safe for you to participate.
- he study team is not confident tat you have a diagnosis of PD
Schedule of Visits
The study will last for a minimum of 5 years; for some participants it may last as long as 7 years. During the first year of the study you will be seen a minimum of four times. During the second year, you will be seen at least two times. Thereafter, your will be seen every year for an in –person visit and have a telephone consultation between visits. It may be necessary for you to have an extra visits if you are having concerns about your PD or if you laboratory test need to be repeated.
For more information about NET-PD, please
Call 1-800-352-9424 or
Visit www.parkinsontrial.org
Delaware Valley contact is:
Rea York at 215-586-5955
To read more about this study, please download this pdf.
The Parkinson Council, its Directors, employees, agents, and affiliates, assume no responsibility for consequences resulting from the information contained in this section. The Parkinson Council makes no representations concerning the matters listed in this section and is not responsible for and expressly disclaims all liability for damages of any kind arising from the content of this section, email and/or its attachments. It is incumbent upon any person volunteering or assisting another person to conduct his or her own due diligence concerning the study and the medical personnel conducting it.